US equities
|
NVDA
$239.76
▲+0.36%
MU
$1,052.13
▼-1.11%
SPCX
$172.54
▲+0.85%
MRVL
$289.60
▲+6.76%
AMD
$653.87
▲+3.50%
INTC
$114.08
▼-1.81%
AVGO
$377.37
▲+4.10%
TSLA
$380.13
▲+0.37%
NVDA
$239.76
▲+0.36%
MU
$1,052.13
▼-1.11%
SPCX
$172.54
▲+0.85%
MRVL
$289.60
▲+6.76%
AMD
$653.87
▲+3.50%
INTC
$114.08
▼-1.81%
AVGO
$377.37
▲+4.10%
TSLA
$380.13
▲+0.37%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NASDAQ:APLS
Recent news which mentions NASDAQ:APLS
APLS Stock Earnings: Apellis Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
May 07, 2024
Tickers
APLS
Tags
APLS
NASDAQ:APLS
Earnings Reports
From
InvestorPlace
Apellis Pharmaceuticals stock has lost 40% in 2024: buy the dip?
April 30, 2024
Tickers
APLS
USA
Tags
USA
Stock Market
NASDAQ:APLS
From
Invezz
Better Pharmaceutical Stock: Apellis or Novartis?
September 14, 2021
Tags
NASDAQ:APLS
NYSE:NVS
From
StockNews.com
APLS Stock: The Trial Results That Have Apellis Pharmaceuticals Plunging Today
September 10, 2021
Tickers
APLS
Tags
NASDAQ:APLS
APLS
Market News
From
InvestorPlace